Literature DB >> 6698611

Comparison of immunomodulatory activities in mice and guinea pigs of a synthetic desmuramyl peptidolipid triglymyc.

C D Leclerc, F M Audibert, L A Chedid, E J Deriaud, N K Masihi, E Lederer.   

Abstract

A nonpyrogenic desmuramyl peptidolipid, 1-O-(L-alanyl-D-isoglutaminyl-L-alanyl-glycerol-mycolate), had previously been shown to be inactive as adjuvant in guinea pigs, but to be very active in stimulating nonspecific resistance. We now show that 1-O-(L-alanyl-D-isoglutaminyl-L-alanyl-glycerol-mycolate) is capable of enhancing or suppressing the immune responses in mice when injected with or before an antigen. In vivo suppression of the immune response to sheep erythrocytes was also observed with high doses of murabutide, a nonpyrogenic adjuvant-active N-acetylmuramyl-L-alanyl-D-isoglutamine analog. Chemiluminescence measurements with mouse spleen cells show a very strong activity of 1-O-(L-alanyl-D-isoglutaminyl-L-alanyl-glycerol-mycolate) by far superior to the effect obtained with the corresponding muramyl peptide, N-acetylmuramyl-L-alanyl-D-isoglutaminyl-L-alanyl-glycerol-myco late.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6698611      PMCID: PMC264263          DOI: 10.1128/iai.43.3.870-875.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  The mode of action of immunologic adjuvants.

Authors:  J FREUND
Journal:  Bibl Tuberc       Date:  1956

2.  Adjuvant activity of monomeric bacterial cell wall peptidoglycans.

Authors:  A Adam; R Ciorbaru; F Ellouz; J F Petit; E Lederer
Journal:  Biochem Biophys Res Commun       Date:  1974-02-04       Impact factor: 3.575

3.  The mode of action of mineral-oil emulsion adjuvants on antibody production in mice.

Authors:  W J Herbert
Journal:  Immunology       Date:  1968-03       Impact factor: 7.397

4.  Isolation and properties of a macromolecular, water-soluble, immuno-adjuvant fraction from the cell wall of Mycobacterium smegmatis.

Authors:  A Adam; R Ciorbaru; J F Petit; E Lederer
Journal:  Proc Natl Acad Sci U S A       Date:  1972-04       Impact factor: 11.205

5.  Further improvements in the plaque technique for detecting single antibody-forming cells.

Authors:  A J Cunningham; A Szenberg
Journal:  Immunology       Date:  1968-04       Impact factor: 7.397

Review 6.  Synthetic immunostimulants derived from the bacterial cell wall.

Authors:  E Lederer
Journal:  J Med Chem       Date:  1980-08       Impact factor: 7.446

7.  Stimulation of chemiluminescence by synthetic muramyl dipeptide and analogs.

Authors:  K N Masihi; I Azuma; W Brehmer; W Lange
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

8.  Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity.

Authors:  L A Chedid; M A Parant; F M Audibert; G J Riveau; F J Parant; E Lederer; J P Choay; P L Lefrancier
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

9.  Studies on a new immunoactive peptide, FK-156. II. Fermentation, extraction and chemical and biological characterization.

Authors:  T Gotoh; K Nakahara; T Nishiura; M Hashimoto; T Kino; Y Kuroda; M Okuhara; M Kohsaka; H Aoki; H Imanaka
Journal:  J Antibiot (Tokyo)       Date:  1982-10       Impact factor: 2.649

10.  Immunochemical study of antigenic specificity in delayed hypersensitivity. V. Immunization with monovalent low molecular weight conjugates.

Authors:  S Leskowitz; V E Jones; S J Zak
Journal:  J Exp Med       Date:  1966-02-01       Impact factor: 14.307

View more
  4 in total

1.  Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice.

Authors:  J A Montaraz; A J Winter
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

2.  Immune-related edemagenic activity of glutamines and glutamic acid, components of immunomodulatory agents.

Authors:  Z Zídek
Journal:  Agents Actions       Date:  1994-10

3.  Colony-stimulating activity induced by synthetic muramyl peptides: variation with chemical structure and association with anti-infectious activity.

Authors:  A Galelli; P Lefrancier; L Chedid
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

Review 4.  Translation of peptidoglycan metabolites into immunotherapeutics.

Authors:  Matthew E Griffin; Charles W Hespen; Yen-Chih Wang; Howard C Hang
Journal:  Clin Transl Immunology       Date:  2019-11-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.